A homoeostatic switch causing glycerol-3-phosphate and phosphoethanolamine accumulation triggers senescence by rewiring lipid metabolism.


Journal

Nature metabolism
ISSN: 2522-5812
Titre abrégé: Nat Metab
Pays: Germany
ID NLM: 101736592

Informations de publication

Date de publication:
Feb 2024
Historique:
received: 30 03 2023
accepted: 21 12 2023
medline: 27 2 2024
pubmed: 27 2 2024
entrez: 26 2 2024
Statut: ppublish

Résumé

Cellular senescence affects many physiological and pathological processes and is characterized by durable cell cycle arrest, an inflammatory secretory phenotype and metabolic reprogramming. Here, by using dynamic transcriptome and metabolome profiling in human fibroblasts with different subtypes of senescence, we show that a homoeostatic switch that results in glycerol-3-phosphate (G3P) and phosphoethanolamine (pEtN) accumulation links lipid metabolism to the senescence gene expression programme. Mechanistically, p53-dependent glycerol kinase activation and post-translational inactivation of phosphate cytidylyltransferase 2, ethanolamine regulate this metabolic switch, which promotes triglyceride accumulation in lipid droplets and induces the senescence gene expression programme. Conversely, G3P phosphatase and ethanolamine-phosphate phospho-lyase-based scavenging of G3P and pEtN acts in a senomorphic way by reducing G3P and pEtN accumulation. Collectively, our study ties G3P and pEtN accumulation to controlling lipid droplet biogenesis and phospholipid flux in senescent cells, providing a potential therapeutic avenue for targeting senescence and related pathophysiology.

Identifiants

pubmed: 38409325
doi: 10.1038/s42255-023-00972-y
pii: 10.1038/s42255-023-00972-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

323-342

Informations de copyright

© 2024. The Author(s).

Références

Gorgoulis, V. et al. Cellular senescence: defining a path forward. Cell 179, 813–827 (2019).
pubmed: 31675495 doi: 10.1016/j.cell.2019.10.005
Wiley, C. D. & Campisi, J. The metabolic roots of senescence: mechanisms and opportunities for intervention. Nat. Metab. 3, 1290–1301 (2021).
pubmed: 34663974 pmcid: 8889622 doi: 10.1038/s42255-021-00483-8
Neurohr, G. E. et al. Excessive cell growth causes cytoplasm dilution and contributes to senescence. Cell 176, 1083–1097 (2019).
pubmed: 30739799 pmcid: 6386581 doi: 10.1016/j.cell.2019.01.018
Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. PNAS 92, 9363–9367 (1995).
pubmed: 7568133 pmcid: 40985 doi: 10.1073/pnas.92.20.9363
Childs, B. G. et al. Senescent cells: an emerging target for diseases of ageing. Nat. Rev. Drug Discov. 16, 718–735 (2017).
pubmed: 28729727 pmcid: 5942225 doi: 10.1038/nrd.2017.116
Zwerschke, W. et al. Metabolic analysis of senescent human fibroblasts reveals a role for AMP in cellular senescence. Biochem. J. 376, 403–411 (2003).
pubmed: 12943534 pmcid: 1223775 doi: 10.1042/bj20030816
Unterluggauer, H. et al. Premature senescence of human endothelial cells induced by inhibition of glutaminase. Biogerontology 9, 247–259 (2008).
pubmed: 18317946 doi: 10.1007/s10522-008-9134-x
Flor, A. C., Wolfgeher, D., Wu, D. & Kron, S. J. A signature of enhanced lipid metabolism, lipid peroxidation and aldehyde stress in therapy-induced senescence. Cell Death Discov. 3, 17075 (2017).
pubmed: 29090099 pmcid: 5661608 doi: 10.1038/cddiscovery.2017.75
Johmura, Y. et al. Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders. Science 371, 265–270 (2021).
pubmed: 33446552 doi: 10.1126/science.abb5916
Chan, M. et al. Novel insights from a multiomics dissection of the Hayflick limit. eLife https://doi.org/10.7554/eLife.70283 (2022).
Quijano, C. et al. Oncogene-induced senescence results in marked metabolic and bioenergetic alterations. Cell Cycle 11, 1383–1392 (2012).
pubmed: 22421146 pmcid: 3350879 doi: 10.4161/cc.19800
Ogrodnik, M. et al. Obesity-induced cellular senescence drives anxiety and impairs neurogenesis. Cell Metab. 29, 1233 (2019).
pubmed: 31067450 pmcid: 6509279 doi: 10.1016/j.cmet.2019.01.013
Wiley, C. D. et al. Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. Cell Metab. 23, 303–314 (2016).
pubmed: 26686024 doi: 10.1016/j.cmet.2015.11.011
Marschallinger, J. et al. Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat. Neurosci. 23, 194–208 (2020).
pubmed: 31959936 pmcid: 7595134 doi: 10.1038/s41593-019-0566-1
Saitou, M. et al. An evolutionary transcriptomics approach links CD36 to membrane remodeling in replicative senescence. Mol. Omics 14, 237–246 (2018).
pubmed: 29974107 doi: 10.1039/C8MO00099A
Fafian-Labora, J. et al. FASN activity is important for the initial stages of the induction of senescence. Cell Death Dis. 10, 318 (2019).
pubmed: 30962418 pmcid: 6453932 doi: 10.1038/s41419-019-1550-0
Kim, W. et al. Polyunsaturated fatty acid desaturation is a mechanism for glycolytic NAD(+) recycling. Cell Metab. 29, 856–870 (2019).
pubmed: 30686744 pmcid: 6447447 doi: 10.1016/j.cmet.2018.12.023
Santinon, G. et al. dNTP metabolism links mechanical cues and YAP/TAZ to cell growth and oncogene-induced senescence. EMBO J. https://doi.org/10.15252/embj.201797780 (2018).
Romani, P. et al. Extracellular matrix mechanical cues regulate lipid metabolism through lipin-1 and SREBP. Nat. Cell Biol. 21, 338–347 (2019).
pubmed: 30718857 doi: 10.1038/s41556-018-0270-5
Martinez-Zamudio, R. I. et al. AP-1 imprints a reversible transcriptional programme of senescent cells. Nat. Cell Biol. 22, 842–855 (2020).
pubmed: 32514071 pmcid: 7899185 doi: 10.1038/s41556-020-0529-5
Hernandez-Segura, A. et al. Unmasking transcriptional heterogeneity in senescent cells. Curr. Biol. 27, 2652–2660 e2654 (2017).
pubmed: 28844647 pmcid: 5788810 doi: 10.1016/j.cub.2017.07.033
Basisty, N. et al. A proteomic atlas of senescence-associated secretomes for aging biomarker development. PLoS Biol. 18, e3000599 (2020).
pubmed: 31945054 pmcid: 6964821 doi: 10.1371/journal.pbio.3000599
Morris, J. P. T. et al. α-ketoglutarate links p53 to cell fate during tumour suppression. Nature 573, 595–599 (2019).
pubmed: 31534224 pmcid: 6830448 doi: 10.1038/s41586-019-1577-5
Pospelova, T. V. et al. Suppression of replicative senescence by rapamycin in rodent embryonic cells. Cell Cycle 11, 2402–2407 (2012).
pubmed: 22672902 doi: 10.4161/cc.20882
Blagosklonny, M. V. Geroconversion: irreversible step to cellular senescence. Cell Cycle 13, 3628–3635 (2014).
pubmed: 25483060 pmcid: 4614001 doi: 10.4161/15384101.2014.985507
Roh, K. et al. Lysosomal control of senescence and inflammation through cholesterol partitioning. Nat. Metab. https://doi.org/10.1038/s42255-023-00747-5 (2023).
doi: 10.1038/s42255-023-00747-5 pubmed: 36864206
Losman, J. A., Koivunen, P. & Kaelin, W. G. Jr. 2-Oxoglutarate-dependent dioxygenases in cancer. Nat. Rev. Cancer 20, 710–726 (2020).
pubmed: 33087883 doi: 10.1038/s41568-020-00303-3
Manni, W., Jianxin, X., Weiqi, H., Siyuan, C. & Huashan, S. JMJD family proteins in cancer and inflammation. Signal Transduct. Target Ther. 7, 304 (2022).
pubmed: 36050314 pmcid: 9434538 doi: 10.1038/s41392-022-01145-1
Wu, S. K., Ariffin, J., Tay, S. C. & Picone, R. The variant senescence-associated secretory phenotype induced by centrosome amplification constitutes a pathway that activates hypoxia-inducible factor-1α. Aging Cell 22, e13766 (2023).
pubmed: 36660875 pmcid: 10014068 doi: 10.1111/acel.13766
Hu, S. et al. Stabilization of HIF-1α alleviates osteoarthritis via enhancing mitophagy. Cell Death Dis. 11, 481 (2020).
pubmed: 32587244 pmcid: 7316774 doi: 10.1038/s41419-020-2680-0
Rasmussen, K. D. & Helin, K. Role of TET enzymes in DNA methylation, development, and cancer. Genes Dev. 30, 733–750 (2016).
pubmed: 27036965 pmcid: 4826392 doi: 10.1101/gad.276568.115
van Vliet, T. et al. Physiological hypoxia restrains the senescence-associated secretory phenotype via AMPK-mediated mTOR suppression. Mol. Cell 81, 2041–2052 (2021).
pubmed: 33823141 doi: 10.1016/j.molcel.2021.03.018
Wichelecki, D. J. et al. Discovery of function in the enolase superfamily: D-mannonate and D-gluconate dehydratases in the D-mannonate dehydratase subgroup. Biochemistry 53, 2722–2731 (2014).
pubmed: 24697546 doi: 10.1021/bi500264p
Kamburov, A., Cavill, R., Ebbels, T. M., Herwig, R. & Keun, H. C. Integrated pathway-level analysis of transcriptomics and metabolomics data with IMPaLA. Bioinformatics 27, 2917–2918 (2011).
pubmed: 21893519 doi: 10.1093/bioinformatics/btr499
Jiang, P., Du, W., Mancuso, A., Wellen, K. E. & Yang, X. Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence. Nature 493, 689–693 (2013).
pubmed: 23334421 pmcid: 3561500 doi: 10.1038/nature11776
Vassilev, L. T. et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303, 844–848 (2004).
pubmed: 14704432 doi: 10.1126/science.1092472
Coppe, J. P. et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6, 2853–2868 (2008).
pubmed: 19053174 doi: 10.1371/journal.pbio.0060301
Freund, A., Patil, C. K. & Campisi, J. p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J. 30, 1536–1548 (2011).
pubmed: 21399611 pmcid: 3102277 doi: 10.1038/emboj.2011.69
Wiley, C. D. et al. Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype. Sci. Rep. 8, 2410 (2018).
pubmed: 29402901 pmcid: 5799282 doi: 10.1038/s41598-018-20000-4
Mugabo, Y. et al. Identification of a mammalian glycerol-3-phosphate phosphatase: role in metabolism and signaling in pancreatic β-cells and hepatocytes. PNAS 113, E430–E439 (2016).
pubmed: 26755581 pmcid: 4743820 doi: 10.1073/pnas.1514375113
Seltzer, W. K., Dhariwal, G., McKelvey, H. A. & McCabe, E. R. 1-Thioglycerol: inhibitor of glycerol kinase activity in vitro and in situ. Life Sci. 39, 1417–1424 (1986).
pubmed: 3022087 doi: 10.1016/0024-3205(86)90545-X
Pavlovic, Z. & Bakovic, M. Regulation of phosphatidylethanolamine homeostasis: the critical role of CTP:phosphoethanolamine cytidylyltransferase (Pcyt2). Int. J. Mol. Sci. 14, 2529–2550 (2013).
pubmed: 23354482 pmcid: 3588000 doi: 10.3390/ijms14022529
Pavlovic, Z. et al. Isoform-specific and protein kinase C-mediated regulation of CTP:phosphoethanolamine cytidylyltransferase phosphorylation. J. Biol. Chem. 289, 9053–9064 (2014).
pubmed: 24519946 pmcid: 3979399 doi: 10.1074/jbc.M113.544932
Schiroli, D. & Peracchi, A. A subfamily of PLP-dependent enzymes specialized in handling terminal amines. Biochim. Biophys. Acta 1854, 1200–1211 (2015).
pubmed: 25770684 doi: 10.1016/j.bbapap.2015.02.023
Grapentine, S. et al. Pcyt2 deficiency causes age-dependant development of nonalcoholic steatohepatitis and insulin resistance that could be attenuated with phosphoethanolamine. Sci. Rep. 12, 1048 (2022).
pubmed: 35058529 pmcid: 8776951 doi: 10.1038/s41598-022-05140-y
Barradas, M. et al. Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS. Genes Dev. 23, 1177–1182 (2009).
pubmed: 19451218 pmcid: 2685533 doi: 10.1101/gad.511109
Liu, Y. et al. Akt phosphorylates the transcriptional repressor bmi1 to block its effects on the tumor-suppressing ink4a-arf locus. Sci. Signal. 5, ra77 (2012).
pubmed: 23092893 pmcid: 3784651 doi: 10.1126/scisignal.2003199
Cha, T. L. et al. Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3. Science 310, 306–310 (2005).
pubmed: 16224021 doi: 10.1126/science.1118947
Ladraa, S. et al. PIK3CA gain-of-function mutation in adipose tissue induces metabolic reprogramming with Warburg-like effect and severe endocrine disruption. Sci. Adv. 8, eade7823 (2022).
pubmed: 36490341 pmcid: 9733923 doi: 10.1126/sciadv.ade7823
Bardeesy, N. et al. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev. 20, 3130–3146 (2006).
pubmed: 17114584 pmcid: 1635148 doi: 10.1101/gad.1478706
Harrison, D. E. et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392–395 (2009).
pubmed: 19587680 pmcid: 2786175 doi: 10.1038/nature08221
Zhdanov, A. V., Okkelman, I. A., Collins, F. W., Melgar, S. & Papkovsky, D. B. A novel effect of DMOG on cell metabolism: direct inhibition of mitochondrial function precedes HIF target gene expression. Biochim. Biophys. Acta 1847, 1254–1266 (2015).
pubmed: 26143176 doi: 10.1016/j.bbabio.2015.06.016
Kamphorst, J. J. et al. Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. PNAS 110, 8882–8887 (2013).
pubmed: 23671091 pmcid: 3670379 doi: 10.1073/pnas.1307237110
Hosios, A. M. et al. mTORC1 regulates a lysosome-dependent adaptive shift in intracellular lipid species. Nat. Metab. 4, 1792–1811 (2022).
pubmed: 36536136 pmcid: 9799240 doi: 10.1038/s42255-022-00706-6
Baraibar, M. A. et al. Impaired energy metabolism of senescent muscle satellite cells is associated with oxidative modifications of glycolytic enzymes. Aging 8, 3375–3389 (2016).
pubmed: 27922824 pmcid: 5270674 doi: 10.18632/aging.101126
Possik, E. et al. New mammalian glycerol-3-phosphate phosphatase: role in β-cell, liver and adipocyte metabolism. Front. Endocrinol. 12, 706607 (2021).
doi: 10.3389/fendo.2021.706607
Taylor, A., Grapentine, S., Ichhpuniani, J. & Bakovic, M. Choline transporter-like proteins 1 and 2 are newly identified plasma membrane and mitochondrial ethanolamine transporters. J. Biol. Chem. 296, 100604 (2021).
pubmed: 33789160 pmcid: 8081925 doi: 10.1016/j.jbc.2021.100604
Cikes, D. et al. PCYT2-regulated lipid biosynthesis is critical to muscle health and ageing. Nat. Metab. 5, 495–515 (2023).
pubmed: 36941451 doi: 10.1038/s42255-023-00766-2
Al-Mass, A. et al. Hepatic glycerol shunt and glycerol-3-phosphate phosphatase control liver metabolism and glucodetoxification under hyperglycemia. Mol. Metab. 66, 101609 (2022).
pubmed: 36198384 pmcid: 9579801 doi: 10.1016/j.molmet.2022.101609
Al-Mass, A. et al. Glycerol-3-phosphate phosphatase operates a glycerol shunt in pancreatic β-cells that controls insulin secretion and metabolic stress. Mol. Metab. 60, 101471 (2022).
pubmed: 35272070 pmcid: 8972011 doi: 10.1016/j.molmet.2022.101471
Possik, E. et al. Phosphoglycolate phosphatase homologs act as glycerol-3-phosphate phosphatase to control stress and healthspan in C. elegans. Nat. Commun. 13, 177 (2022).
pubmed: 35017476 pmcid: 8752807 doi: 10.1038/s41467-021-27803-6
Lee, S. J., Murphy, C. T. & Kenyon, C. Glucose shortens the life span of C. elegans by downregulating DAF-16/FOXO activity and aquaporin gene expression. Cell Metab. 10, 379–391 (2009).
pubmed: 19883616 pmcid: 2887095 doi: 10.1016/j.cmet.2009.10.003
Hibuse, T. et al. Aquaporin 7 deficiency is associated with development of obesity through activation of adipose glycerol kinase. PNAS 102, 10993–10998 (2005).
pubmed: 16009937 pmcid: 1182435 doi: 10.1073/pnas.0503291102
Singh, R. K., Fullerton, M. D., Vine, D. & Bakovic, M. Mechanism of hypertriglyceridemia in CTP:phosphoethanolamine cytidylyltransferase-deficient mice. J. Lipid Res. 53, 1811–1822 (2012).
pubmed: 22764088 pmcid: 3413222 doi: 10.1194/jlr.M021881
Goldstein, I. et al. p53 promotes the expression of gluconeogenesis-related genes and enhances hepatic glucose production. Cancer Metab. 1, 9 (2013).
pubmed: 24280180 pmcid: 4178212 doi: 10.1186/2049-3002-1-9
Fontana, D. et al. ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine. Nat. Commun. 11, 5938 (2020).
pubmed: 33230096 pmcid: 7684297 doi: 10.1038/s41467-020-19721-w
Gohil, V. M. et al. Meclizine inhibits mitochondrial respiration through direct targeting of cytosolic phosphoethanolamine metabolism. J. Biol. Chem. 288, 35387–35395 (2013).
pubmed: 24142790 pmcid: 3853286 doi: 10.1074/jbc.M113.489237
Mackay, G. M., Zheng, L., van den Broek, N. J. & Gottlieb, E. Analysis of cell metabolism using LC-MS and isotope tracers. Methods Enzymol. 561, 171–196 (2015).
pubmed: 26358905 doi: 10.1016/bs.mie.2015.05.016
Kumar, V. et al. A keratin scaffold regulates epidermal barrier formation, mitochondrial lipid composition, and activity. J. Cell Biol. 211, 1057–1075 (2015).
pubmed: 26644517 pmcid: 4674273 doi: 10.1083/jcb.201404147
Ozbalci, C., Sachsenheimer, T. & Brugger, B. Quantitative analysis of cellular lipids by nano-electrospray ionization mass spectrometry. Methods Mol. Biol. 1033, 3–20 (2013).
pubmed: 23996167 doi: 10.1007/978-1-62703-487-6_1
Benit, P. et al. Three spectrophotometric assays for the measurement of the five respiratory chain complexes in minuscule biological samples. Clin. Chim. Acta 374, 81–86 (2006).
pubmed: 16828729 doi: 10.1016/j.cca.2006.05.034
Roccio, F. et al. Monitoring lipophagy in kidney epithelial cells in response to shear stress. Methods Cell. Biol. 164, 11–25 (2021).
pubmed: 34225909 doi: 10.1016/bs.mcb.2020.12.003
Chen, R., Plouffe, S. W. & Guan, K. L. Determining the phosphorylation status of hippo components YAP and TAZ using phos-tag. Methods Mol. Biol. 1893, 281–287 (2019).
pubmed: 30565141 doi: 10.1007/978-1-4939-8910-2_21
Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 9, 559 (2008).
doi: 10.1186/1471-2105-9-559
Kanehisa, M. & Goto, S. KEGG: Kyoto Encyclopedia of Genes And Genomes. Nucleic Acids Res. 28, 27–30 (2000).
pubmed: 10592173 pmcid: 102409 doi: 10.1093/nar/28.1.27
Johnson, W. E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118–127 (2007).
pubmed: 16632515 doi: 10.1093/biostatistics/kxj037
Carvalho, B. S. & Irizarry, R. A. A framework for oligonucleotide microarray preprocessing. Bioinformatics 26, 2363–2367 (2010).
pubmed: 20688976 pmcid: 2944196 doi: 10.1093/bioinformatics/btq431
Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E. & Storey, J. D. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28, 882–883 (2012).
pubmed: 22257669 pmcid: 3307112 doi: 10.1093/bioinformatics/bts034
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
pubmed: 25605792 pmcid: 4402510 doi: 10.1093/nar/gkv007
Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).
pubmed: 34557778 pmcid: 8454663
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. PNAS 102, 15545–15550 (2005).
pubmed: 16199517 pmcid: 1239896 doi: 10.1073/pnas.0506580102
Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417–425 (2015).
pubmed: 26771021 pmcid: 4707969 doi: 10.1016/j.cels.2015.12.004
Thevenot, E. A., Roux, A., Xu, Y., Ezan, E. & Junot, C. Analysis of the human adult urinary metabolome variations with age, body mass index, and gender by implementing a comprehensive workflow for univariate and OPLS statistical analyses. J. Proteome Res. 14, 3322–3335 (2015).
pubmed: 26088811 doi: 10.1021/acs.jproteome.5b00354
Rusilowicz, M., Dickinson, M., Charlton, A., O’Keefe, S. & Wilson, J. A batch correction method for liquid chromatography-mass spectrometry data that does not depend on quality control samples. Metabolomics 12, 56 (2016).
pubmed: 27069441 pmcid: 4757603 doi: 10.1007/s11306-016-0972-2
Wehrens, R. et al. Improved batch correction in untargeted MS-based metabolomics. Metabolomics 12, 88 (2016).
pubmed: 27073351 pmcid: 4796354 doi: 10.1007/s11306-016-1015-8
Siddiqui, J. K. et al. IntLIM: integration using linear models of metabolomics and gene expression data. BMC Bioinform. 19, 81 (2018).
doi: 10.1186/s12859-018-2085-6
Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847–2849 (2016).
pubmed: 27207943 doi: 10.1093/bioinformatics/btw313
Ono, K., Muetze, T., Kolishovski, G., Shannon, P. & Demchak, B. CyREST: turbocharging cytoscape access for external tools via a RESTful API. F1000Res 4, 478 (2015).
pubmed: 26672762 pmcid: 4670004 doi: 10.12688/f1000research.6767.1
Gustavsen, J. A., Pai, S., Isserlin, R., Demchak, B. & Pico, A. R. RCy3: network biology using Cytoscape from within R. F1000Res 8, 1774 (2019).
pubmed: 31819800 pmcid: 6880260 doi: 10.12688/f1000research.20887.2
Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).
pubmed: 14597658 pmcid: 403769 doi: 10.1101/gr.1239303
Haug, K. et al. MetaboLights: a resource evolving in response to the needs of its scientific community. Nucleic Acids Res. 48, D440–D444 (2020).
pubmed: 31691833

Auteurs

Khaled Tighanimine (K)

Université Paris Cité, CNRS, Inserm, Institut Necker Enfants Malades (INEM), Paris, France.

José Américo Nabuco Leva Ferreira Freitas (JA)

IMRB, Mondor Institute for Biomedical Research, Inserm U955, Université Paris Est Créteil, UPEC, Faculté de Médecine de Créteil 8, Créteil, France.
Sorbonne Université, CNRS, INSERM, Institut de Biologie Paris Seine, Biological Adaptation and Ageing (B2A-IBPS), Paris, France.

Ivan Nemazanyy (I)

Platform for Metabolic Analyses, Structure Fédérative de Recherche Necker, INSERM US24/CNRS UAR 3633, Paris, France.

Alexia Bankolé (A)

Université Paris Cité, CNRS, Inserm, Institut Necker Enfants Malades (INEM), Paris, France.

Delphine Benarroch-Popivker (D)

Université Côte d'Azur, Inserm, CNRS, Institut for Research on Cancer and Aging (IRCAN), Nice, France.

Susanne Brodesser (S)

University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases (CECAD), Cologne, Germany.

Gregory Doré (G)

Institut Pasteur, Plasmodium RNA Biology Unit, Paris, France.

Lucas Robinson (L)

Institut Pasteur, Department of Cell Biology and Infection, INSERM, Paris, France.

Paule Benit (P)

Université Paris Cité, Inserm U1141, NeuroDiderot, Paris, France.

Sophia Ladraa (S)

Université Paris Cité, CNRS, Inserm, Institut Necker Enfants Malades (INEM), Paris, France.

Yara Bou Saada (YB)

Sorbonne Université, CNRS, INSERM, Institut de Biologie Paris Seine, Biological Adaptation and Ageing (B2A-IBPS), Paris, France.

Bertrand Friguet (B)

Sorbonne Université, CNRS, INSERM, Institut de Biologie Paris Seine, Biological Adaptation and Ageing (B2A-IBPS), Paris, France.

Philippe Bertolino (P)

Equipe Labellisée la Ligue Contre le Cancer, Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR 5286, Centre Léon Bérard, Université de Lyon, Lyon, France.

David Bernard (D)

Equipe Labellisée la Ligue Contre le Cancer, Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR 5286, Centre Léon Bérard, Université de Lyon, Lyon, France.

Guillaume Canaud (G)

Université Paris Cité, CNRS, Inserm, Institut Necker Enfants Malades (INEM), Paris, France.
Unité de médecine translationnelle et thérapies ciblées, Hôpital Necker-Enfants Malades, AP-HP, Paris, France.

Pierre Rustin (P)

Université Paris Cité, Inserm U1141, NeuroDiderot, Paris, France.

Eric Gilson (E)

Université Côte d'Azur, Inserm, CNRS, Institut for Research on Cancer and Aging (IRCAN), Nice, France.
Department of Medical Genetics, University-Hospital (CHU) of Nice, Nice, France.

Oliver Bischof (O)

IMRB, Mondor Institute for Biomedical Research, Inserm U955, Université Paris Est Créteil, UPEC, Faculté de Médecine de Créteil 8, Créteil, France. oliver.bischof@cnrs.fr.

Stefano Fumagalli (S)

Université Paris Cité, CNRS, Inserm, Institut Necker Enfants Malades (INEM), Paris, France. stefano.fumagalli@inserm.fr.

Mario Pende (M)

Université Paris Cité, CNRS, Inserm, Institut Necker Enfants Malades (INEM), Paris, France. mario.pende@inserm.fr.

Classifications MeSH